GlassScriptPhysician profile
James A Roth
NPI 1679527618
$6,520.96
in general payments reported to CMS, 2019-2025
17 companies · $65.53 in 2025
The $65.53 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $125 · 2021: $2,319 · 2022: $140 · 2023: $2,867 · 2024: $283 · 2025: $65.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,833 · Travel and Lodging: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,833.03 |
| Travel and Lodging | $1,382.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,197.72 | 2021-2024 | Arctic Front Advance, Micra, Pulseselect |
| Atricure, INC. | $815.80 | 2019-2021 | |
| Boston Scientific Corporation | $539.29 | 2019-2025 | Rhythmia Mapping System, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $267.75 | 2019-2022 | |
| Medtronic Vascular, INC. | $168.71 | 2019 | |
| Pfizer INC. | $125.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2020 | |
| Abbott Laboratories | $66.76 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $40.02 | 2022 | |
| Chiesi USA, INC. | $31.72 | 2022-2023 | Cleviprex, Kengreal |
| Shockwave Medical, INC | $25.54 | 2022 | |
| Heartflow, INC. | $23.57 | 2025 | |
| Abiomed | $22.07 | 2024 | Impella |
| Amgen INC. | $21.39 | 2021 | |
| Cardiva Medical, INC. | $18.81 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.11 | 2024 | Lifevest |
| Teleflex LLC | $15.70 | 2025 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Roth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.